Lexicon Pharmaceuticals (LXRX) Inventory Average (2017 - 2026)
Lexicon Pharmaceuticals (LXRX) reported Inventory Average of $278500.0 for Q1 2026, up 28.94% year-over-year from $216000.0 in Q1 2025, and up 26.88% quarter-over-quarter from $219500.0 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Inventory Average (2017 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 8 years of Inventory Average data on file, last reported at $278500.0 in Q1 2026.
- Inventory Average for Q1 2026 came in at $278500.0, up 28.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $278500.0 (up 28.94% YoY), and the FY2025 annual result was $256000.0, down 16.34% from the prior year.
- Inventory Average climbed to $278500.0 in Q1 2026 per LXRX's latest filing, from $219500.0 in the prior quarter.
- Over five years, Inventory Average peaked at $610500.0 in Q3 2024 and troughed at $163000.0 in Q3 2025.
- A 4-year average of $337727.3 and a median of $278500.0 in 2026 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2024 and 2025: Inventory Average surged 140.35% in 2024, then sank 73.3% in 2025.
- A 4-year view of Inventory Average shows it stood at $358500.0 in 2023, then gained by 20.92% to $433500.0 in 2024, then plunged by 49.37% to $219500.0 in 2025, then climbed by 26.88% to $278500.0 in 2026.
- Business Quant data shows LXRX's Inventory Average at $278500.0 in Q1 2026, $219500.0 in Q4 2025, and $163000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 804.48 Mn | 633.82 Mn | 20.99 Mn | 278,500.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 278,500.00 |
| Dec 31, 2025 | 219,500.00 |
| Sep 30, 2025 | 163,000.00 |
| Jun 30, 2025 | 184,500.00 |
| Mar 31, 2025 | 216,000.00 |
| Dec 31, 2024 | 433,500.00 |
| Sep 30, 2024 | 610,500.00 |
| Jun 30, 2024 | 549,500.00 |
| Mar 31, 2024 | 447,500.00 |
| Dec 31, 2023 | 358,500.00 |
| Sep 30, 2023 | 254,000.00 |
| Jun 30, 2020 | 4.07 Mn |
| Mar 31, 2020 | 4.20 Mn |
| Dec 31, 2019 | 4.36 Mn |
| Sep 30, 2019 | 4.38 Mn |
| Jun 30, 2019 | 4.44 Mn |
| Mar 31, 2019 | 4.64 Mn |
| Dec 31, 2018 | 4.72 Mn |
| Sep 30, 2018 | 3.45 Mn |
| Jun 30, 2018 | 2.13 Mn |